Learning objectives

After watching this webinar, participants will be able to review:

• recent guidelines and data on mitral valve regurgitation management contained in the 2020 ACC Guidelines and in the 2021 SMR HF paper signed by the HFA/EHRA/EACVI/EAPCI;

• new 2021 ESC/EACTS/HF Guidelines for Management of Valvular Heart Disease as indicated in RCTs and registries; and

• meta-analysis outcomes evaluating the EVEREST/COAPT/MITRA-FR randomised clinical trials that support indications in the guidelines.

Needs assessment and expected educational outcome

To discuss how to implement mitral valve regurgitation management into clinical practice. ​

Main Topic

• VALVULAR, MYOCARDIAL, PERICARDIAL, PULMONARY, CONGENITAL HEART DISEASE     

Related topic

• Valvular Heart Disease

Session information

This webinar is designed for all cardiologists interested by Valvular Heart Disease (Heart Failure, Interventionalist, Imaging specialist, Surgeon) but also cardiologists wishing to update their scientific knowledge on the topic.

During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.

Technical settings

The webinar is available on PC and tablets. The use of a smartphone is not recommended.

To answer the MCQs during the live, you must allow pop-up windows.

A high-speed Internet connection is required (minimum 2 Mbps).